Your browser doesn't support javascript.
loading
[A new pathophysiological element in severe asthma: GTPase Rac]. / Un nouvel acteur physiopathologique dans l'asthme sévère : la GTPase Rac.
Hassoun, D; Loirand, G; Sauzeau, V.
Afiliação
  • Hassoun D; Université de Nantes, CHU de Nantes, CNRS, Inserm, institut du thorax, 44000 Nantes, France.
  • Loirand G; Université de Nantes, CNRS, Inserm, institut du thorax, 44000 Nantes, France.
  • Sauzeau V; Université de Nantes, CNRS, Inserm, institut du thorax, 44000 Nantes, France. Electronic address: vincent.sauzeau@inserm.fr.
Rev Mal Respir ; 39(2): 100-103, 2022 Feb.
Article em Fr | MEDLINE | ID: mdl-35183407
ABSTRACT
Asthma is a chronic airway condition defined by hyperresponsiveness, bronchial remodeling and chronic inflammation. A significant proportion of severe asthmatic patients remain uncontrolled despite recent therapeutic breakthroughs (biotherapies). Better understanding of the signaling pathways involved in the pathophysiological mechanisms underlying severe asthma could successfully address this unmet need. Rac GTPase acts as a molecular switch and has already been convincingly associated with airway hyperresponsiveness and bronchial remodeling in asthma. Having been elucidated by acquired knowledge regarding other pathologies. Its role in the inflammation mechanisms characterizing asthma is currently under specific evaluation.
Assuntos
Palavras-chave

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Hipersensibilidade Respiratória / Asma / GTP Fosfo-Hidrolases Limite: Humans Idioma: Fr Revista: Rev Mal Respir Ano de publicação: 2022 Tipo de documento: Article País de afiliação: França

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Hipersensibilidade Respiratória / Asma / GTP Fosfo-Hidrolases Limite: Humans Idioma: Fr Revista: Rev Mal Respir Ano de publicação: 2022 Tipo de documento: Article País de afiliação: França